ARCHIVES

In Breif: FDA Issues Uterine Cancer-Tamoxifin Warning; Fisher Declined Invitation To Speak At AACR

This article is from The Cancer Letter archive.

Vol. 20 No. 15 | April 15, 1994

Download PDF Visit The Full Archive

Related Articles

Mihich to Be Sixth New NCAB appointee; Centers Worried About Core Grants, Role In 200 AD Goals

May 25, 1984

Four Patients In Tamoxifin Treatment Trial Had Died of Uterine Cancer Prior To BCPT

April 29, 1994

Senate Passes Extension Ac; Kennedy Plans Saccharin Hearing

May 13, 1977

Oncology Nurse “Cinderella’s” Need Specialty Status

November 23, 1974

AACI Statement On Cancer Centers Presented to Reform Task Force

April 9, 1993

NCI Clarifies Policy On Small, Short-Term Research Grants

July 5, 1996